| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/13/2008 | US20080280832 Novel Fsh Glycosylation Variant D3n |
| 11/13/2008 | US20080280831 Chimeric proteins with phosphatidylserine binding domains |
| 11/13/2008 | US20080280829 Inhibition of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2); osteoporosis, osteopenia; use of 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)-aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one |
| 11/13/2008 | US20080280828 Compositions Comprising Igbpma and Uses Thereof |
| 11/13/2008 | US20080280827 peptide(s) capable of inhibiting the TGF- beta activation reaction. The present invention provides a peptide consisting of 11 to 50 amino acid residues, which comprises an amino acid sequence Gln-Ile-Leu-Ser-X1-X2-X3-X4-Ala-Ser-Pro (SEQ ID NO: 1) wherein each of X1 to X4 independently represents |
| 11/13/2008 | US20080280826 for promoting osteogenesis to accelerate or enhance bone fracture healing, treat bone defects, and enhance bone formation are disclosed. The methods modulate an arachidonic acid metabolic or signaling pathway in general, and, in particular, utilize 5-lipoxygenase inhibitors. |
| 11/13/2008 | US20080280825 Protective BF protein, protective C2 protein; sample, diagnosis, prophylaxis, therapy of dysregulation of complement mediated disease; membrane proliferative glomerulonephritis |
| 11/13/2008 | US20080280824 Compositions and methods for treatment of cancer or neurodegenerative disease with peptide based microtubule stabilizers or inhibitors |
| 11/13/2008 | US20080280823 Treatment of Non-Alcoholic Steatotic Hepatitis (Nash) |
| 11/13/2008 | US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
| 11/13/2008 | US20080280821 Polynucleotide encoding the amino acid sequence; DNA sequence which encodes a protein; expression vector gene; cell line; multiple myeloma, leukemia, brain glioma, lung cancer and colon cancer |
| 11/13/2008 | US20080280820 Novel Peptides for Use in the Treatment of Obesity |
| 11/13/2008 | US20080280819 Methods for promoting hair growth |
| 11/13/2008 | US20080280818 Glycosylation of peptides via o-linked glycosylation sequences |
| 11/13/2008 | US20080280817 Modified amino acid is N-(-5-chlorosalicyloyl)-8-aminocaprylic acid; active agents are heparin, insulin, parathyroid hormone, calcitonin; cardiovascular disorders |
| 11/13/2008 | US20080280816 Methods and pharmaceutical compositions for healing wounds |
| 11/13/2008 | US20080280815 Lowering Serum Lipids |
| 11/13/2008 | US20080280814 Pharmaceutical Compositions Containing Insulin and Insulinotropic Peptide |
| 11/13/2008 | US20080280813 Complex drug delivery composition and method for treating cancer |
| 11/13/2008 | US20080280812 Purified supernatant from Ntera2/D1-derived neurons; polyacrylamide gel electrophoresis produces 20 isoelectric fractions, including active isoelectric fraction #10; Blue Sepharose column to bind albumin; collect free fraction |
| 11/13/2008 | US20080280811 Carbonic Anhydrase-1 and 2 signal inhibitor; of Vascular Endothelial Growth Factor signal inhibitor; kallikrein, kinin pathway inhibitor; Complement-1 Inhibitor agonist; injection into vitreous or aqueous humor of the eye; candidates by tested for significant difference in level of protein, mRNA |
| 11/13/2008 | US20080280810 Coupled to various benefit agents to provide peptide-based body surface reagents; isolate phage-peptide-body surface complex; identify strongly bound phage-peptides using polymerase chain reaction; deliver personal care benefit agents for hair, skin, teeth, gums |
| 11/13/2008 | US20080280354 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 11/13/2008 | US20080280344 Subtilase Variants Having Altered Immunogenictiy |
| 11/13/2008 | US20080280327 Expression vector comprising nucleotide sequences coding bone morphogenic protein/selectin fusion for use in treatment and prvention of inflammatory diseases |
| 11/13/2008 | US20080280326 Peptide comprising luteinizing hormone releasing hormone activity for use as tool in designing treatments for brain disorders; pesticides |
| 11/13/2008 | US20080280322 Transgenic cell for use as bioreactor in production of human estrogen receptor (HER) specific monoclonal antibody for use in targeted destruction of tumor cells |
| 11/13/2008 | US20080280308 G protein coupled receptor signaling modulation |
| 11/13/2008 | US20080279965 Treatment Of Injury To The Brain By Inhibition Of Acid Sensing ION Channels |
| 11/13/2008 | US20080279955 Pharmaceutical microparticles |
| 11/13/2008 | US20080279953 Methods of producing stable pancreatic enzyme compositions |
| 11/13/2008 | US20080279950 Nano-particles comprising cucurbituril derivatives, pharmaceutical composition containing the same, and process for the preparation thereof |
| 11/13/2008 | US20080279946 Methods and compositions for increasing infrared absorptivity of a target |
| 11/13/2008 | US20080279939 Using a mixture of tissue sources; regeneration in situ |
| 11/13/2008 | US20080279932 Vildagliptin salt; in mixture with therapeutic agents such as antidiabetic agents; antilipemic agents; obesity; appetite control; hypotensive agents; cholesterol absorption moderators; anticoagulants; estrogen receptor moderators; transferring across blood-brain barrier |
| 11/13/2008 | US20080279925 Method(s) of preventing, arresting, reversing and treatment of atherosclerosis |
| 11/13/2008 | US20080279924 HLA class I A2 tumor associated antigen peptides and vaccine compositions |
| 11/13/2008 | US20080279923 Use of Microtubule Stabilizing Compounds for the Treatment of Lesions of Cns Axons |
| 11/13/2008 | US20080279919 Liposomes for protection against toxic compounds |
| 11/13/2008 | US20080279913 Reduces oxidative stresses of the eye; using iron chelate compound |
| 11/13/2008 | US20080279909 Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization |
| 11/13/2008 | US20080279906 Intracellular delivery of endothelial growth factor |
| 11/13/2008 | US20080279897 Method of Treating Cellular Damage |
| 11/13/2008 | US20080279893 Lawsonia intracellularis immunological proteins |
| 11/13/2008 | US20080279887 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 11/13/2008 | US20080279880 Peptide vaccines against group a streptococci |
| 11/13/2008 | US20080279874 Compositions and methods for modulation of plk1 kinase activity |
| 11/13/2008 | US20080279873 Active immunization to generate antibodies to soluble a-beta |
| 11/13/2008 | US20080279872 Using dendritic cells expressing chymotrypsin protein fragment as immunostimulatory tool for targeting cancer cells associated with ovarian tissue |
| 11/13/2008 | US20080279871 Immunogenic composition |
| 11/13/2008 | US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells |
| 11/13/2008 | US20080279864 High Throughput Screen Utilizing Newly Discovered Intramolecular Neuronal Calcium Channel Interactions To Discover New Analgesics |
| 11/13/2008 | US20080279862 Using interleukin-1 specfic immunoglobulin fusion and tumor necrosis factor inhibitors to treat inflammatory and/or autoimmune disorders |
| 11/13/2008 | US20080279856 Using heparin-binding protein specific monoclonal antibody to decrease nonapeptide separation; prevention and treatment of inflammation |
| 11/13/2008 | US20080279855 Dna Replication Modulating Peptides, Nucleic Acids Encoding Them, and Their Use in Pharmaceutical Compositions |
| 11/13/2008 | US20080279852 Methods of treatment with glycosylated antibodies |
| 11/13/2008 | US20080279846 lipoprotein-associated phospholipase A2 (Lp-PLA2) |
| 11/13/2008 | US20080279845 Combination therapy with a compound acting as a platelet adp receptor inhibitor |
| 11/13/2008 | US20080279843 Using concentration of inflammation marker protein as evaluative signal for enzyme inhibitor dispension; drug delivery and antidiabetic agents |
| 11/13/2008 | US20080279842 Surgical bandage comprising proteolytic enzymes incorporated into a degradable polymeric material; less painful removal of damaged tissue |
| 11/13/2008 | US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof |
| 11/13/2008 | US20080279840 Treating vision and skin disorders with amine oxidase therapeutics |
| 11/13/2008 | US20080279839 Composition With a Fungal (Yeast) Lipase and Method For Treating Lipid Malabsorption in Cystic Fibrous as Well as People Suffering From Pancreatic Lipase Insufficiency |
| 11/13/2008 | US20080279838 Reconstructed Human Mariner Transposon Capable of Stable Gene Transfer Into Chromosomes in Vertebrates |
| 11/13/2008 | US20080279824 Articles for tissue regeneration with biodegradable polymer |
| 11/13/2008 | US20080279823 Modified cytokine for use in tredatment and prevention of autoimmune, cell proliferative targeting and infectious disorders |
| 11/13/2008 | US20080279822 Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand |
| 11/13/2008 | US20080279821 Arylpiperidinyl and arylpyrrolidinyl macrocyclic hepatitis c serine protease inhibitors |
| 11/13/2008 | US20080279820 Compositions and Methods for Treating Burns |
| 11/13/2008 | US20080279819 Therapeutic mixture comprising uncompetitive n-methylaspartic acid receptor antagonist, glatiramer acetate and monoclonal antibody for use in treatment of multiple sclerosis |
| 11/13/2008 | US20080279818 Therapeutic mixture comprising antisense agents, chemotherapeutic compounds and bile extract for use in treatment of cell proliferative disorders |
| 11/13/2008 | US20080279817 Treatment of Autoimmune Diseases and Allograft Rejection with IL-21 |
| 11/13/2008 | US20080279816 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity; multiple sclerosis |
| 11/13/2008 | US20080279815 Method for developing testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
| 11/13/2008 | US20080279814 Using interleukin-5 mixture as therapeutic tool in treatment of nervous system disorders |
| 11/13/2008 | US20080279813 Using interferon and interleukin receptor expression profiles as evaluative tools in diagnosis of cancer, autoimmune, allergic, transplant rejection and infectious disorders |
| 11/13/2008 | US20080279812 Disease Prevention and Vaccination Prior to Thymic Reactivation |
| 11/13/2008 | US20080279786 Method for Extending Lifespan Delaying the Onset of Age-Related Disease |
| 11/13/2008 | US20080279785 Novel synthetic agonists of toll-like receptors containing CG dinucleotide modifications |
| 11/13/2008 | US20080279764 Method and composition for treating cancer |
| 11/13/2008 | CA2727939A1 Methods and compositions for use of cyclic analogues of histatin |
| 11/13/2008 | CA2723320A1 Il-12 immunotherapy for cancer |
| 11/13/2008 | CA2688653A1 Glycan modified soluble receptors and binding proteins and their use |
| 11/13/2008 | CA2687395A1 Complement factor h-derived short consensus repeat-antibody constructs |
| 11/13/2008 | CA2686861A1 Interferon alpha-induced pharmacodynamic markers |
| 11/13/2008 | CA2686722A1 Methods for treating and preventing gi syndrome and graft versus host disease |
| 11/13/2008 | CA2686234A1 Use of cyclosporines in the treatment of patients with intraocular lenses |
| 11/13/2008 | CA2685873A1 Self-precipitating pharmaceutical formulations for the modified release of active principle |
| 11/13/2008 | CA2685853A1 Composition for transmucosal delivery of polypeptides |
| 11/13/2008 | CA2685686A1 Compositions and methods for increasing vascularization |
| 11/13/2008 | CA2685596A1 Modified interferon beta polypeptides and their uses |
| 11/13/2008 | CA2685568A1 Methods of modulating cellular homeostatic pathways and cellular survival |
| 11/13/2008 | CA2685417A1 Viral vector for gene therapy |
| 11/13/2008 | CA2684922A1 Cytotoxic t cell activator comprising ep4 agonist |
| 11/13/2008 | CA2684908A1 Implantable system for an intervertebral disc and intervertebral disc implant |
| 11/12/2008 | EP1990427A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction |
| 11/12/2008 | EP1990415A1 Osteoprotegerin |
| 11/12/2008 | EP1990413A1 Screening method for candidate drugs |
| 11/12/2008 | EP1990059A2 Methods for treating cancer |
| 11/12/2008 | EP1990058A1 Aglyco products and their use for inhibiting infection by influenza virus, and useof hexosamine precursor in schizophrenia treatment |